← Eichor
Condition: Geographic Atrophy Ga Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Geographic Atrophy Ga

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Phase 1/2 Study to Evaluate the Safety and Efficacy of Intravitreal Administration of BS01 in Patients With Geographic
Phase 1/Phase 2 · 1 location(s) · Bionic Sight LLC · NCT07158775
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Phase 2 · 57 location(s) · ONL Therapeutics · NCT06659445
A Study to Evaluate the Safety and Effect of TO-O-1007 Intravitreal Implant in Subjects With Geographic Atrophy
Phase 1/Phase 2 · 3 location(s) · Theratocular Biotek Co. · NCT07668804
Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants
Phase 1 · 8 location(s) · Regeneron Pharmaceuticals · NCT07230834
An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx001 is Safe and Works for People With Geog
Phase 1/Phase 2 · 5 location(s) · Complement Therapeutics · NCT07392255
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Se
Phase 2 · 104 location(s) · Janssen Research & Development, LLC · NCT06635148
SGLT2 Inhibitors in Geographic Atrophy
Phase 2 · 1 location(s) · Washington University School of Medicine · NCT07174687
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult
Phase 3 · 218 location(s) · Regeneron Pharmaceuticals · NCT06541704
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
Phase 2 · 27 location(s) · ADARx Pharmaceuticals, Inc. · NCT06990269
Central micrOperimetry and Radial OCT Evaluation in Geographic Atrophy (CORE-GA): a Prospective Pilot Study
Phase N/A · 1 location(s) · University of California, San Francisco · NCT07556406
Lesion-tailored, Fundus-controlled Perimetry in Geographic Atrophy (GA).
Phase N/A · 1 location(s) · University of Utah · NCT07582042
A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)
Phase N/A · 13 location(s) · Complement Therapeutics · NCT07144137
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.